HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis.

AbstractOBJECTIVES:
To describe imaging and laboratory findings of confirmed PE diagnosed in COVID-19 patients and to evaluate the characteristics of COVID-19 patients with clinical PE suspicion. Characteristics of patients with COVID-19 and PE suspicion who required admission to the intensive care unit (ICU) were also analysed.
METHODS:
A retrospective study from March 18, 2020, until April 11, 2020. Inclusion criteria were patients with suspected PE and positive real-time reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2. Exclusion criteria were negative or inconclusive RT-PCR and other chest CT indications. CTPA features were evaluated and severity scores, presence, and localisation of PE were reported. D-dimer and IL-6 determinations, ICU admission, and previous antithrombotic treatment were registered.
RESULTS:
Forty-seven PE suspicions with confirmed COVID-19 underwent CTPA. Sixteen patients were diagnosed with PE with a predominant segmental distribution. Statistically significant differences were found in the highest D-dimer determination in patients with PE and ICU admission regarding elevated IL-6 values.
CONCLUSION:
PE in COVID-19 patients in our series might predominantly affect segmental arteries and the right lung. Results suggest that the higher the D-dimer concentration, the greater the likelihood of PE. Both assumptions should be assessed in future studies with a larger sample size.
KEY POINTS:
• On CT pulmonary angiography, pulmonary embolism in COVID-19 patients seems to be predominantly distributed in segmental arteries of the right lung, an assumption that needs to be approached in future research. • Only the highest intraindividual determination of d-dimer from admission to CT scan seems to differentiate patients with pulmonary embolism from patients with a negative CTPA. However, interindividual variability calls for future studies to establish cut-off values in COVID-19 patients. • Further studies with larger sample sizes are needed to determine whether the presence of PE could increase the risk of intensive care unit (ICU) admission in COVID-19 patients.
AuthorsIrene Espallargas, Juan José Rodríguez Sevilla, Diego Agustín Rodríguez Chiaradía, Antonio Salar, Guillem Casamayor, Judit Villar-Garcia, Anna Rodó-Pin, Salvatore Marsico, Santiago Carbullanca, Diego Ramal, Luis Alexander Del Carpio, Ángel Gayete, José María Maiques, Flavio Zuccarino
JournalEuropean radiology (Eur Radiol) Vol. 31 Issue 4 Pg. 1915-1922 (Apr 2021) ISSN: 1432-1084 [Electronic] Germany
PMID32964337 (Publication Type: Journal Article)
Topics
  • COVID-19
  • Humans
  • Pulmonary Embolism (diagnostic imaging)
  • Retrospective Studies
  • SARS-CoV-2
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: